Molecular Cancer ResearchCancer BiologyPeer-reviewed journal article
Differential control of growth and identity by HNF4α isoforms in pancreatic ductal adenocarcinoma
Pengshu FangiD, Emily R. WilsoniD, Sydney N. LarseniD, Walter A. OrellanaiD, Margaret A HalliD, Chris StubbeniD, Acramul Haque KabiriD, Kajsa E. AffolteriD, Richard A. MoffittiD, Xiaoyang ZhangiD, Eric L. SnyderiD
Abstract
BackgroundAlthough transcriptomic studies have stratified pancreatic ductal adenocarcinoma (PDAC) into clinically relevant subtypes, classical or basal-like, further research is needed to identify the transcriptional regulators of each subtype. Previous studies identified HNF4 as a key regulator of the classical subtype, but the distinct contributions of its isoforms (P1 and P2), which display dichotomous functions in normal development and gastrointestinal malignancies, remain unexplored. ObjectiveThe objective of this study is to investigate the role of HNF4 P1 and P2 isoforms in regulating growth and differentiation. DesignWe performed functional, transcriptomic, and epigenetic analysis after exogenous expression in HNF4-negative models or CRISPRi-mediated knockdown of endogenous isoforms. ResultsWe characterized the variable expression of P1 isoforms in HNF4-positive tumors. We demonstrate that P1 isoforms are less compatible with growth than P2 isoforms. Despite sharing a common DNA binding domain, we show that P1 isoforms are stronger transcriptional regulators. ConclusionsOur study characterizes the functional roles of HNF4 P1 and P2 isoforms in PDAC and highlights the necessity of considering different isoforms when studying molecular regulators.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- Citations
- 4
- FWCI
- 1.66
- Field percentile
- top 15%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4
S. A. Camolotto, V. Belova, … E. Snyder·bioRxiv·Oct 22, 2019
- HNF1A is a Novel Oncogene and Central Regulator of Pancreatic Cancer Stem Cells
E. Abel, M. Goto, … D. M. Simeone·bioRxiv·Dec 22, 2017
- HNF1A is a novel BRD4 target and critical for BET-inhibitor response in pancreatic ductal adenocarcinoma
Kennedy S. Humphrey, Katherine J. Crawford, … Ethan V. Abel·Communications BiologyPeer-reviewed·Jul 30, 2026
- Targeting FGFR4 Abrogates HNF1A-driven Metastasis in Pancreatic Ductal Adenocarcinoma
Katherine J. Crawford, Kennedy S. Humphrey, … Ethan V. Abel·Molecular CancerPeer-reviewed·Jul 29, 2025
- Regulation of HDAC2-PDX1 by RNF125 defines pancreatic cancer development
E. Hasnis, H. Kim, … Z. A. Ronai·bioRxiv·Jan 6, 2020
- HNF1A recruits UTX to activate a differentiation program that suppresses pancreatic cancer
Mark Kalisz, Edgar Bernardo, … Jorge P. Ferrer·The EMBO JournalPeer-reviewed·Mar 10, 2020